AL
Anavex Life Sciences Corp
🇺🇸XNAS.AVXLUnited StatesHealthcare
$2.36USDdown -0.07 (-2.88%)ClosedDelayed2:14 AM
Price$2.36-0.07 (-2.88%)
Profile
- Healthcare
- Biotechnology
- United States
Identity
- Exchange
- Nasdaq . XNAS
- Type
- Stock
- ISIN
- US0327973006
- CUSIP
- 032797102
Company
- Employees
- 34
- Headquarters
- New York, United States
- Website
- https://www.anavex.com
- CEO
- Dr. Terrie Kellmeyer Ph.D.
Market
- Shares outstanding
- 92.7M
- Market cap
- $218.76M
Highlights
- Market cap
- $225.25M
- EPS LTM
- -$0.26
- P/E LTM
- -9.93
- Div yield
- Not reported
Fundamentals (LTM)
- Revenue
- $00%unchanged year on year
- Net income
- -$24.04M+50.09%up year on year
- Gross margin
- Not reported
- Free cash flow
- -$33.73M+9.08%up year on year
Other listings
These are the venues Finzer covers, not every venue that exists.
Business summary
No company summary reported yet.